News IXICO plc

Stocks

IXI

GB00BFXR4C20

Biotechnology & Medical Research

Delayed London S.E. 02:55:39 29/10/26 am AEDT			5-day change	1st Jan Change
12.00 ^GBX	+2.13%		+41.18%	+2.13%

23/10	Synthomer is cash positive; Arbuthnot lifts outlook	AN
22/10	Ixico Wins New Contract, Extension Totaling GBP1.5 Million	MT

All News

Mentions Relevance

22/10	Ixico Wins New Contract, Extension Totaling GBP1.5 Million	MT
22/10	IXICO plc Announces Two Contracts In Alzheimer?s Disease Worth £1.5 Million	CI
21/10	Ixico stock rises as forecasts full-year revenue and earnings beat	AN
20/10	WINNERS & LOSERS: Ixico beats expectations; Shearwater wins deal	AN
02/10	IXICO plc Presents Advancements In Neuroimaging For Parkinson?s Disease At European Radiology Conference	CI
13/07	Ixico notes ending of Huntington's disease programmes	AN
13/07	WINNERS & LOSERS: Ixico lower order book; Pennant sees revenue jump	AN
13/07	Ixico Says Two Huntington's Disease Programs Discontinued by Sponsors	MT
07/07	IXICO plc Provides Earnings Guidance for the Year Ending 30 September 2026	CI
07/07	Ixico ups guidance; Steppe Cement revenue up	AN
08/06	Ixico plc Announces Appointments on Scientific Advisory Board	CI
08/06	Ixico Has Enters into A Research Collaboration with the Paris Brain Institute	CI
22/05	IXICO plc, H1 2026 Earnings Call, May 19, 2026
21/05	BTG to beat expectations; Sabre backs outlook	AN
21/05	Ixico Bags New Contract, Extension Worth GBP1.3 Million	MT
21/05	Ixico announces contract win & extension with total value of £1.3 million over 2 years	RE
21/05	Ixico plc Announces Contract Win and Extension	CI
20/05	Ixico reaffirms growth guidance as half-year revenue rises	AN
19/05	Ixico remains focused on delivering on guidance of 15% revenue growth for full year	RE
19/05	Earnings Flash (IXI.L) Ixico plc Reports Fiscal H1 Revenue GBP3.9M	MT
19/05	IXICO plc Reaffirms Earnings Guidance for the Full Year 2026	CI
19/05	IXICO plc Reports Earnings Results for the Half Year Ended March 31, 2026	CI
12/05	IXICO Plc Releases Latest Version Of AI-Driven Neuroimaging Technology Platform	CI
21/04	Ixico plc Provides Earnings Guidance for the First Half Ended 31 March 2026	CI
07/04	Ixico Completes Retail Stock Offering	MT